Predictors of Fracture in Older Women With Osteopenic Hip Bone Mineral Density Treated With Zoledronate

T ‐Score as an Indicator of Fracture Risk During Treatment With Romosozumab or Alendronate in the ARCH Trial

(2020) Felicia Cosman et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials

(2020) Dennis M Black et al.   Lancet Diabetes & Endocrinology

No more fracture trials in osteoporosis?

(2020) Ian R Reid   Lancet Diabetes & Endocrinology

Anti‐Fracture Efficacy of Zoledronate in Subgroups of Osteopenic Postmenopausal Women: Secondary Analysis of a Randomized Controlled Trial

(2019) Ian R Reid et al.   JOURNAL OF INTERNAL MEDICINE

Relationship Between Bone Mineral Density T‐score and Nonvertebral Fracture Risk Over 10 Years of Denosumab Treatment

(2019) S Ferrari et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Change in Bone Density and Reduction in Fracture Risk: A Meta-Regression of Published Trials

(2019) Mary L Bouxsein et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Fracture Prevention with Zoledronate in Older Women with Osteopenia

(2018) Ian R. Reid et al.   NEW ENGLAND JOURNAL OF MEDICINE

Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis

(2017) Kenneth G. Saag et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reassessment of Fracture Risk in Women After 3 Years of Treatment With Zoledronic Acid: When is it Reasonable to Discontinue Treatment?

(2014) Felicia Cosman et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Relationship of changes in total hip bone mineral density to vertebral and nonvertebral fracture risk in women with postmenopausal osteoporosis treated with once-yearly zoledronic acid 5 mg: The HORIZON-Pivotal Fracture Trial (PFT)

(2012) Richard M Jacques et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Does osteoporosis therapy invalidate FRAX for fracture prediction?

(2012) William D Leslie et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Relationship between bone mineral density changes with denosumab treatment and risk reduction for vertebral and nonvertebral fractures

(2011) Matthew Austin et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Vertebral fracture assessment using a semiquantitative technique

(2010) Harry K. Genant et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial

(2010) Ann V Schwartz et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis

(2009) Steven R. Cummings et al.   NEW ENGLAND JOURNAL OF MEDICINE

FRAX™ and the assessment of fracture probability in men and women from the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL